Literature DB >> 29316224

Resistant hypertension: a therapeutic challenge.

Laura Brandani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29316224      PMCID： PMC8030975          DOI： 10.1111/jch.13144

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  27 in total

1.  Urinary albumin excretion is associated with true resistant hypertension.

Authors:  A Oliveras; P Armario; R Hernández-Del Rey; J A Arroyo; E Poch; M Larrousse; A Roca-Cusachs; A de la Sierra
Journal:  J Hum Hypertens       Date:  2010-01       Impact factor: 3.012

2.  Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.

Authors:  Britta Vogel; Michael Kirchberger; Martin Zeier; Felicitas Stoll; Benjamin Meder; Daniel Saure; Martin Andrassy; Oliver J Mueller; Stefan Hardt; Vedat Schwenger; Anna Strothmeyer; Hugo A Katus; Erwin Blessing
Journal:  Clin Res Cardiol       Date:  2013-10-15       Impact factor: 5.460

3.  Changes in albumin-to-creatinine ratio at 12-month follow-up in patients undergoing renal denervation.

Authors:  Henrique Sousa; Patrícia Branco; Manuel de Sousa Almeida; Pedro de Araújo Gonçalves; Augusta Gaspar; Hélder Dores; João Mesquita; Maria João Andrade; Nuno Neuparth; Ana Aleixo; Miguel Mendes; José Diogo Barata
Journal:  Rev Port Cardiol       Date:  2017-04-26       Impact factor: 1.374

Review 4.  Resistant hypertension and target organ damage.

Authors:  Maria Lorenza Muiesan; Massimo Salvetti; Damiano Rizzoni; Anna Paini; Claudia Agabiti-Rosei; Carlo Aggiusti; Enrico Agabiti Rosei
Journal:  Hypertens Res       Date:  2013-04-18       Impact factor: 3.872

5.  Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.

Authors:  Oliver Chung; Wanpen Vongpatanasin; Klaus Bonaventura; Yair Lotan; Christian Sohns; Wilhelm Haverkamp; Marc Dorenkamp
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

6.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

7.  First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.

Authors:  Michael Böhm; Felix Mahfoud; Christian Ukena; Uta C Hoppe; Krzysztof Narkiewicz; Manuela Negoita; Luis Ruilope; Markus P Schlaich; Roland E Schmieder; Robert Whitbourn; Bryan Williams; Uwe Zeymer; Andreas Zirlik; Giuseppe Mancia
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

8.  Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.

Authors:  Lukas Kaiser; Thomas Beister; Andrea Wiese; Jasper von Wedel; Felix Meincke; Felix Kreidel; Andreas Busjahn; Karl-Heinz Kuck; Martin W Bergmann
Journal:  EuroIntervention       Date:  2014-05       Impact factor: 6.534

9.  Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension.

Authors:  Gil F Salles; Roberto Fiszman; Claudia R L Cardoso; Elizabeth S Muxfeldt
Journal:  Hypertension       Date:  2007-07-16       Impact factor: 10.190

Review 10.  Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance.

Authors:  David A Calhoun
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.